The team developed 5n, a potential prostate cancer inhibitor, to disrupt the disease's survival tactics through molecular sabotage ...

The International Society for Stem Cell Research (ISSCR) announces the launch of a new online continuing education course, ...

These newly announced products, along with Rincell's existing high-energy silicon-graphite cells - the 4.1Ah 18650 (RC41) and ...

A new study reveals the biological secret to the Zika virus's infectious success: Zika uses host cells' own "self-care" ...

Researchers have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance promises to improve diabetes research and cell-based therapies.

Researchers led by Maike Sander, Scientific Director of the Max Delbrück Center, have developed a vascularized organoid model of hormone secreting cells in the pancreas.

Millions of people around the world suffer from chronic low back pain, often finding relief only through temporary solutions ...

From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...

Model more closely replicates natural environment of the pancreas, which will be essential for studying diabetes and ...

Premier Energis and Sino-American Silicon Products Inc to establish a 2GW per annum silicon wafer manufacturing facility in ...

Somatic hypermutation (SHM) of immunoglobulin variable (V) regions modulates antibody-antigen affinity is initiated by activation-induced cytidine deaminase (AID) on single-stranded DNA (ssDNA).

Swedish thin film solar specialist Midsummer announced the order of a SEK 143.5 million ($14.8 million) turnkey line with a capacity for 15 MW from an undisclosed Swedish industrial and defense group.